Page last updated: 2024-09-04

ampelopsin and Colitis

ampelopsin has been researched along with Colitis in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Dong, S; Hu, L; Jing, W; Lu, H; Wang, K; Wang, S; Zhao, X; Zhu, M	1

Other Studies

1 other study(ies) available for ampelopsin and Colitis

Article	Year
Dihydromyricetin improves DSS-induced colitis in mice via modulation of fecal-bacteria-related bile acid metabolism. Pharmacological research, 2021, Volume: 171 Topics: Animals; Anti-Inflammatory Agents; Bacteria; Bile Acids and Salts; Caco-2 Cells; Colitis; Colon; Dextran Sulfate; Dysbiosis; Fecal Microbiota Transplantation; Feces; Flavonols; Gastrointestinal Microbiome; Humans; Interleukin-1beta; Male; Mice, Inbred C57BL; Receptors, Cytoplasmic and Nuclear; Receptors, G-Protein-Coupled; Tumor Necrosis Factor-alpha	2021

Article

Year

Dihydromyricetin improves DSS-induced colitis in mice via modulation of fecal-bacteria-related bile acid metabolism.

Pharmacological research, 2021, Volume: 171

Topics: Animals; Anti-Inflammatory Agents; Bacteria; Bile Acids and Salts; Caco-2 Cells; Colitis; Colon; Dextran Sulfate; Dysbiosis; Fecal Microbiota Transplantation; Feces; Flavonols; Gastrointestinal Microbiome; Humans; Interleukin-1beta; Male; Mice, Inbred C57BL; Receptors, Cytoplasmic and Nuclear; Receptors, G-Protein-Coupled; Tumor Necrosis Factor-alpha

2021